Lymphoma Society of America

The Leukemia & Lymphoma Society (LLS) is a global leader in the fight against blood cancer, operating as the largest voluntary health agency dedicated to funding research, providing patient support, and advocating for policy changes. Through its innovative Therapy Acceleration Program (TAP), LLS functions as a venture philanthropy, providing strategic capital and expertise to biotechnology companies and academic institutions to fast-track promising blood cancer treatments. The organization has played a pivotal role in the development of nearly every major breakthrough in blood cancer therapy, including targeted agents and CAR-T cell therapies. LLS also provides extensive resources for patients and healthcare professionals, ensuring that the latest medical advancements reach those in need. Its mission encompasses leukemia, lymphoma, Hodgkin's disease, and myeloma, aiming to cure blood cancers and improve the quality of life for patients and their families.